The European Systemic Risk Board is assessing the $3.1 trillion private credit market for its potential to amplify financial shocks, an adviser said, adding that the watchdog could recommend new regulatory powers to oversee the opaque industry.
Stolt-Nielsen reported a year-over-year decline in second-quarter net profit, but its shares held steady as investors weighed a record performance in its terminals division and signs of recovery in tanker rates.
The IT services provider raised its full-year forecast, citing stronger-than-expected performance in North America and AI-related projects in the UK, sending its stock up over 10%.
The Swiss hospital real estate company opened at its 54 Swiss franc offer price before falling 1.5% in early trading on the Swiss stock exchange.
Goldman Sachs raised its rating on the mining giant to Buy from Neutral, citing favorable fundamentals for key industrial metals and an attractive valuation after a recent de-rating.
Norwegian salmon farmer SalMar has agreed to purchase a majority stake in competitor Måsøval, valuing the company at approximately 4.84 billion NOK and sending its shares up over 14%.
The UK wealth manager's stock rose after it reported net inflows of £226 million for the fiscal year, a significant reversal from the previous year's outflows, driven by a strong fourth quarter.
The UK's benchmark stock index declined as investors reacted to escalating military conflict between the U.S. and Iran, while a failed late-stage drug trial sent shares of AstraZeneca sharply lower.
AstraZeneca's stock experienced a sharp decline after its experimental heart disease drug, Wainua, failed to meet its primary goal in a pivotal late-stage study, jeopardizing billions in potential sales.
